Description

In-vivo CRO refers to the preclinical testing performed for preclinical testing of disease pathology and drug discovery. It provides information regarding the collection and investigation of data for the development of new drugs for the treatment of various indications. According to a report by StrategyHelix, the global oncology based in-vivo cro market is set to increase by US$ 556.7 million during 2022-2028, growing at a CAGR of 6.8% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for oncology based in-vivo cro. The global oncology based in-vivo cro market is segmented on the basis of indication, and region. On the basis of indication, the global oncology based in-vivo cro market has been segmented into blood cancer, solid tumors (syngeneic model, patient-derived xenograft (PDX), xenograft), others. Geographically, the global oncology based in-vivo cro market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global oncology based in-vivo cro market is highly competitive. The leading players in the oncology based in-vivo cro market include Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific SE, Evotec SE, ICON Plc, Laboratory Corporation of America Holdings (Labcorp), Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec Co. Ltd., XenTech SAS.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oncology based in-vivo cro market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Indication: blood cancer, solid tumors (syngeneic model, patient-derived xenograft (PDX), xenograft), others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global oncology based in-vivo cro market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Oncology based in-vivo cro market overview
Part 3. Market breakdown by indication
– Blood cancer
– Solid tumors (syngeneic model, patient-derived xenograft (PDX), xenograft)
– Others
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– Charles River Laboratories International, Inc.
– Crown Bioscience, Inc.
– Eurofins Scientific SE
– Evotec SE
– ICON Plc
– Laboratory Corporation of America Holdings (Labcorp)
– Taconic Biosciences, Inc.
– The Jackson Laboratory
– WuXi AppTec Co., Ltd.
– XenTech SAS
About StrategyHelix
Disclaimer